title: Pneumatosis intestinalis due to 5-fluorouracil chemotherapy.
authors.affiliation: Servicio de Oncología radioterápica, Hospital Clínic de Barcelona, Barcelona, España. Electronic address: wavargas@clinic.ub.es.
authors.forename: Andrés
authors.initials: A
authors.lastname: Vargas
authors.affiliation: Servicio de Radiología, Hospital Clínic de Barcelona, Barcelona, España.
authors.forename: Mario
authors.initials: M
authors.lastname: Pagés
authors.affiliation: Servicio de Oncología Médica, Hospital Clínic de Barcelona, Barcelona, España.
authors.forename: Elvira
authors.initials: E
authors.lastname: Buxó
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy; D004943:Esophagogastric Junction; D005440:Fluid Therapy; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D010102:Oxygen Inhalation Therapy; D010166:Palliative Care; D011006:Pneumatosis Cystoides Intestinalis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000628:therapy; D013274:Stomach Neoplasms / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D002945:Cisplatin; D005472:Fluorouracil